Accordingly, combination of targeting of STAT3 pathway using small molecule inhibitors such as LLL12B and cytotoxic chemotherapy may provide improved therapy in medulloblastoma, because, chemo-resistance has been represented a major therapeutic challenge for recurrent medulloblastoma41,42. This evidence concerns the gene STAT3 and medulloblastoma.